RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cells

Abstract

Withaferin A (WA) exhibits cancer chemopreventive efficacy in preclinical models representative of two different subtypes of breast cancer. However, the mechanism(s) underlying breast cancer chemoprevention by WA is not fully elucidated. We performed RNA‐seq analyses using a non‐tumorigenic mammary epithelial cell line (MCF‐10A) and human breast cancer cells (BCC) belonging to the luminal‐type (MCF‐7), HER2‐enriched (SK‐BR‐3), and basal‐like subtype (MDA‐MB‐231) to identify novel cancer‐selective mechanistic targets of WA. The WA‐regulated transcriptome was strikingly different between MCF‐10A versus BCC. The Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed downregulation of genes associated with cellular senescence in WA‐treated BCC. Consequently, the number of senescence‐associated β‐galactosidase positive cells was decreased significantly in WA‐treated BCC but not in the MCF‐10A cells. WA treatment caused upregulation of senescence marker p21 more robustly in BCC than in MCF‐10A. Breast cancer prevention by WA in rats was also associated with upregulation of p21 protein expression. The Reactome pathway analyses indicated upregulation of genes associated with cellular response to stress/external stimuli in WA‐treated BCC but not in MCF‐10A. Two proteins represented in these pathways (HSPA6 and NRF2) were further investigated. While HSPA6 was dispensable for WA‐mediated apoptosis and autophagy or inhibition of cell migration, the NRF2 knockout cells were more resistant to apoptosis resulting from WA treatment than control cells. Finally, expression of some glycolysis‐related proteins was decreased by WA treatment both in vitro and in vivo. In summary, this study provides novel insights into cancer‐selective pathways affected by WA that may contribute to its chemopreventive efficacy in breast cancer.

Cancer Chemopreventive Role of Dietary Terpenoids by Modulating Keap1-Nrf2-ARE Signaling System—A Comprehensive Update

“…Thus, the enhanced Nrf2 bound with AREs in order to upregulate its downstream antioxidant enzymes. Robust induction of Nrf2 by WFA was recently reported in the treatment of human breast cancer cells [129]. This study concluded that Nrf2 helped in the mediation of apoptosis and autophagy in several breast cancer cells.…”

RNA-Sequencing Reveals Heat Shock 70-kDa Protein 6 (HSPA6) as a Novel Thymoquinone-Upregulated Gene That Inhibits Growth, Migration, and Invasion of Triple-Negative Breast Cancer Cells

“…Although HSPA6 was discovered three decades ago, the functional roles in cancer progression are unclear ( 12 – 14 ). Recently, HSPA6 was discovered to be dispensable for Withaferin A-mediated apoptosis/autophagy or migration inhibition of breast cancer ( 15 ). In this study, RNA-sequencing (RNA-seq) was performed and TQ-targeted gene HSPA6 was successfully identified for TNBC inhibition functionally.…”

Breast Cancer Selective Disruption of Actin Cytoskeleton by Diallyl Trisulfide

“…Apoptotic cell death was quantitated by flow cytometry following staining with Annexin V and PI essentially as described by us previously [ 28 ]. Briefly, the MEFs were plated in 6-well plates at a density of 2 × 105 cells/well and incubated overnight to allow attachment.…”